Post-ERCP Pancreatitis Clinical Trial
Official title:
Comparative Evaluation of Standard Prophylaxis Versus Divided-dose NSAIDs or Hybrid NSAID and N-acetylcysteine Therapy for the Prevention of Post-ERCP Pancreatitis
The investigators aimed to perform a comparative study, evaluating the efficacy of three prophylactic approaches aiming to reduce the risk of post-ERCP pancreatitis, using pharmacologic agents with different mechanisms of action (NSAIDs and/or acetylcysteine) in three different regimens.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02476279 -
Stent vs. Indomethacin for Preventing Post-ERCP Pancreatitis
|
Phase 3 | |
| Unknown status |
NCT01771419 -
Comparison Of Loop-Tip Wire Vs Tradictional Technique In The Cannulation Of The Common Bile Duct
|
N/A | |
| Completed |
NCT04876768 -
Effects of High FIO2 on Post-ERCP Pancreatitis.
|
N/A | |
| Not yet recruiting |
NCT06250803 -
Early Pancreatic Stent Placement for Preventing PEP
|
N/A | |
| Completed |
NCT01912716 -
Rectal Indomethacin in the Prevention of Post-ERCP Pancreatitis
|
Phase 2/Phase 3 | |
| Terminated |
NCT00820612 -
Rectal Indomethacin in the Prevention of Post-endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis in High Risk Patients
|
Phase 4 | |
| Recruiting |
NCT04750044 -
Refeeding in Post-ERCP Pancreatitis
|
N/A | |
| Completed |
NCT03643900 -
The Efficacy of Pancreatic Duct Stenting With Rectal Indomethacin in Preventing Post-ERCP Pancreatitis
|
N/A | |
| Terminated |
NCT03749590 -
Magnesium Sulfate in the Prevention of Post-ERCP Pancreatitis.
|
Phase 3 |